Skip to Content

Surmodics Inc SRDX

Morningstar Rating
$32.07 +0.17 (0.53%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SRDX is trading at a 5% discount.
Price
$32.15
Fair Value
$53.46
Uncertainty
Very High
1-Star Price
$32.91
5-Star Price
$39.20
Economic Moat
Yxpy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SRDX is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$31.90
Day Range
$31.2832.45
52-Week Range
$16.0039.41
Bid/Ask
$26.23 / $51.15
Market Cap
$456.55 Mil
Volume/Avg
28,739 / 62,018

Key Statistics

Price/Earnings (Normalized)
49.34
Price/Sales
3.26
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
376

Comparables

Valuation

Metric
SRDX
301060
688067
Price/Earnings (Normalized)
49.3431.69199.62
Price/Book Value
3.742.122.19
Price/Sales
3.261.745.60
Price/Cash Flow
20.697.0167.66
Price/Earnings
SRDX
301060
688067

Financial Strength

Metric
SRDX
301060
688067
Quick Ratio
3.752.651.25
Current Ratio
4.843.206.28
Interest Coverage
3.753.73
Quick Ratio
SRDX
301060
688067

Profitability

Metric
SRDX
301060
688067
Return on Assets (Normalized)
5.17%0.70%1.02%
Return on Equity (Normalized)
8.16%1.18%1.15%
Return on Invested Capital (Normalized)
8.20%1.24%1.05%
Return on Assets
SRDX
301060
688067
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesNrdjrp$205.8 Bil
SYK
Stryker CorpBlwym$134.3 Bil
MDT
Medtronic PLCNcbpk$111.0 Bil
BSX
Boston Scientific CorpPldpwd$98.5 Bil
EW
Edwards Lifesciences CorpKqlyt$51.2 Bil
DXCM
DexCom IncMmpxq$46.9 Bil
ZBH
Zimmer Biomet Holdings IncZfbk$25.4 Bil
ALGN
Align Technology IncNfpjsj$23.0 Bil
PHG
Koninklijke Philips NV ADRDfjypw$18.4 Bil
PODD
Insulet CorpTsxmcj$11.8 Bil

Sponsor Center